Graf Akcie ANIK (Anika Therapeutics Inc.). Diskuze k akciím ANIK. Aktuální informace ANIK.

Základní informace o společnosti Anika Therapeutics Inc. (Akcie ANIK)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 591.34M
Hodnota podniku (EV) 461.71M
Tržby 136.819M
EBITDA -2.95
Zisk -12.70
Růst v tržbách Q/Q 24.34 %
Růst v tržbách Y/Y 8.98 %
P/E (Cena vůči ziskům) N/A
Forward P/E 578.36
EV/Sales 3.37
EV/EBITDA N/A
EV/EBIT N/A
PEG 3.19
Price/Sales 4.32
P/FCF 86.16
Price/Book 2.17
Účetní hodnota na akcii 19.19
Hotovost na akcii 6.93
FCF vůči ceně 1.16 %
Počet zaměstnanců 277
Tržba na zaměstnance 493.931k
Profit margin -18.38 %
Operating margin -30.88 %
Gross margin 52.91 %
EBIT margin -11.43 %
EBITDA margin -2.15 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -183.33 %
EPS - Očekávaný růst příští rok -53.33 %
Return on assets -3.37 %
Return on equity -4.53 %
ROIC -8.14 %
ROCE -4.86 %
Dluhy/Equity 0.34
Čistý dluh/EBITDA 104.21
Current ratio 4.30
Quick Ratio 3.26
Volatilita 3.00
Beta 0.78
RSI 54.76
Cílová cena analytiků 51
Známka akcie (dle analytiků) 1.67
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 14.423M
Procento shortovaných akcií 11.46 %
Short ratio 16.93 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1993
Země United States

Finanční výsledky akcie ANIK

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$114.61$105.555$113.42$103.379$92.999$105.595
Cost Of Goods Sold$28.747$31.28$27.364$24.027$21.053$20.93
Gross Profit$85.863$74.275$86.056$79.352$71.946$84.665
Research And Development Expenses$16.665$18.19$18.787$10.732$8.987$8.144
SG&A Expenses$34.95$34.336$21.54$18.013$14.825$15.074
Other Operating Income Or Expenses------
Operating Expenses$80.362$83.806$67.691$52.772$44.865$44.148
Operating Income$34.248$21.749$45.729$50.607$48.134$61.447
Total Non-Operating Income/Expense$1.873$1.458$0.473$0.263$0.12$0.058
Pre-Tax Income$36.121$23.207$46.202$50.87$48.254$61.505
Income Taxes$8.928$4.485$14.386$18.323$17.496$23.186
Income After Taxes$27.193$18.722$31.816$32.547$30.758$38.319
Other Income------
Income From Continuous Operations$27.193$18.722$31.816$32.547$30.758$38.319
Income From Discontinued Operations------
Net Income$27.193$18.722$31.816$32.547$30.758$38.319
EBITDA$40.603$27.288$50.019$54.341$51.909$66.153
EBIT$34.248$21.749$45.729$50.607$48.134$61.447
Basic Shares Outstanding141415151515
Shares Outstanding141515151515
Basic EPS$1.93$1.30$2.18$2.22$2.06$2.61
EPS - Earnings Per Share$1.89$1.27$2.11$2.15$2.01$2.51
# 2020 2019 2018 2017 2016 2015
Current Ratio14.394917.977115.782719.370410.211423.0765
Long-term Debt / Capital-----0.0006
Debt/Equity Ratio-----0.0006
Gross Margin74.917570.366275.873776.758377.362180.179
Operating Margin29.882220.604440.318348.952951.757658.1912
EBIT Margin29.882220.604440.318348.952951.757658.1912
EBITDA Margin35.427125.851944.100752.564855.816762.6479
Pre-Tax Profit Margin31.516521.985740.735349.207351.886658.2461
Net Profit Margin23.726617.736728.051531.483233.073536.2887
Asset Turnover0.34660.37830.40130.43030.39450.5477
Inventory Turnover Ratio1.3071.46851.24181.50331.40941.687
Receiveable Turnover4.9665.08094.76053.74594.29526.1564
Days Sales In Receivables73.571.838176.671997.440284.979259.2877
ROE - Return On Equity9.42967.102112.074814.609914.587821.5157
Return On Tangible Equity9.95727.59313.005315.850916.04424.7437
ROA - Return On Assets8.22266.710611.257613.547413.04719.8742
ROI - Return On Investment9.42967.102112.074814.609914.587821.5034
Book Value Per Share20.15518.564217.939215.230314.02211.9915
Operating Cash Flow Per Share0.1972-0.33131.0911-0.9876-0.01320.9208
Free Cash Flow Per Share0.3176-0.05241.4223-1.3126-0.51360.8362